New results support continued development of AAV-based human factor VIII gene therapy
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, August 20, 2018--Gene therapy using an optimized adeno-associated virus (AAV) to deliver the human factor VIII...












